Allakos(ALLK) - 2024 Q2 - Quarterly Results

Exhibit 99.1 Allakos Provides Business Update and Reports Second Quarter 2024 Financial Results SAN CARLOS, Calif., August 7, 2024 (GLOBE NEWSWIRE) – Allakos Inc. (the "Company") (Nasdaq: ALLK), a biotechnology company developing antibodies for the treatment of allergic, inflammatory and proliferative diseases, today provided a business update and reported financial results for the second quarter ended June 30, 2024. Recent Allakos Events • Initiated the randomized, double-blind, placebo-controlled Phase 1 ...